228 related articles for article (PubMed ID: 33658066)
1. The important herbal pair for the treatment of COVID-19 and its possible mechanisms.
Xia S; Zhong Z; Gao B; Vong CT; Lin X; Cai J; Gao H; Chan G; Li C
Chin Med; 2021 Mar; 16(1):25. PubMed ID: 33658066
[TBL] [Abstract][Full Text] [Related]
2. Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study.
Song JB; Zhao LQ; Wen HP; Li YP
J Integr Med; 2023 Nov; 21(6):593-604. PubMed ID: 37805293
[TBL] [Abstract][Full Text] [Related]
3. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
4. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
5. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
[TBL] [Abstract][Full Text] [Related]
6. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
8. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
[TBL] [Abstract][Full Text] [Related]
9. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
BioData Min; 2020; 13():17. PubMed ID: 33082858
[TBL] [Abstract][Full Text] [Related]
10. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
12. Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining.
Yu MX; Song X; Ma XQ; Hao CX; Huang JJ; Yang WH
Ann Palliat Med; 2021 Apr; 10(4):3960-3975. PubMed ID: 33832291
[TBL] [Abstract][Full Text] [Related]
13. Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection.
Li H; Sun M; Lei F; Liu J; Chen X; Li Y; Wang Y; Lu J; Yu D; Gao Y; Xu J; Chen H; Li M; Yi Z; He X; Chen L
Antiviral Res; 2024 Apr; 224():105841. PubMed ID: 38408645
[TBL] [Abstract][Full Text] [Related]
14. [Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence].
Li ZY; Hao EW; Cao R; Lin S; Chen SY; Huang XT; Xu WR; Hou XT; Deng JG
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4765-4777. PubMed ID: 36164884
[TBL] [Abstract][Full Text] [Related]
15. Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3.
Luo W; Ding R; Guo X; Zhan T; Tang T; Fan R; Wang Y
Comput Biol Med; 2022 Jun; 145():105457. PubMed ID: 35366469
[TBL] [Abstract][Full Text] [Related]
16. The mechanism and active compounds of semen
Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
Food Nutr Res; 2021; 65():. PubMed ID: 34908920
[TBL] [Abstract][Full Text] [Related]
17. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
18. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
[TBL] [Abstract][Full Text] [Related]
19. Identification of phytochemical compounds of
Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L
Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
